Skip to main content
Top
Published in: Pediatric Rheumatology 1/2015

Open Access 01-12-2015 | Hypothesis

The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study

Authors: E. Marrani, R. Cimaz, O M Lucherini, R. Caputo, A. Vitale, L. Cantarini, G. Simonini

Published in: Pediatric Rheumatology | Issue 1/2015

Login to get access

Abstract

Background

The etiology of Autoimmune chronic uveitis (ACU) is still unknown; NOD2/CARD15 gene mutations are responsible for the Blau Syndrome and can induce uveitis in animal models.

Presentation of the hypothesis

Aim of our study was to assess if NOD2/CARD15 variants have a role in the etiology or in the clinical course of patients with ACU, either idiopathic or associated with other inflammatory diseases.

Testing the hypothesis

We consecutively enrolled 25 patients (19 pediatric and 6 adults) affected with ACU. For each patient medical history was reviewed and clinical data were recorded. Allelic and genotypic frequencies of NOD2/CARD15 variations were calculated in patients and matched with those of 25 healthy controls. The statistical analysis was performed.
Fifteen patients showed the polymorphism P268S/SNP5 (SNP rs2066842) as heterozygous carriers while two patients were homozygous for the same polymorphism; one patient carried also the variant c647 18–16 TCT on intron 3, not previously reported in the literature. Statistical analysis for NOD2/CARD15 genotyping showed significant differences between patients and controls for allelic frequencies (p = 0.04, OR: 4.03, 95 %; CI = 1.2–13.5) but not for genotypic frequencies. We could not identify a significant phenotype-genotype correlation.

Implications of the hypothesis

In our cohort of Italian patients, the NOD2/CARD15 common variant P268S/SNP5 could potentially be significantly associated with ACU.
Literature
1.
go back to reference Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol. 2013;24:453–62.CrossRefPubMed Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol. 2013;24:453–62.CrossRefPubMed
2.
go back to reference Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1–2.CrossRefPubMed Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1–2.CrossRefPubMed
3.
go back to reference Cantarini L, Simonini G, Frediani B, Pagnini I, Galeazzi M, Cimaz R. Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs. 2012;21:1–6.CrossRefPubMed Cantarini L, Simonini G, Frediani B, Pagnini I, Galeazzi M, Cimaz R. Treatment strategies for childhood noninfectious chronic uveitis: an update. Expert Opin Investig Drugs. 2012;21:1–6.CrossRefPubMed
4.
go back to reference Yang MM, Lai TY, Luk FO, Pang CP. The roles of genetic factors in uveitis and their clinical significance. Retina. 2014;34:1–11.CrossRefPubMed Yang MM, Lai TY, Luk FO, Pang CP. The roles of genetic factors in uveitis and their clinical significance. Retina. 2014;34:1–11.CrossRefPubMed
5.
go back to reference Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009;17:249–56.CrossRefPubMed Du L, Kijlstra A, Yang P. Immune response genes in uveitis. Ocul Immunol Inflamm. 2009;17:249–56.CrossRefPubMed
6.
go back to reference Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One. 2008;3:e2119.PubMedCentralCrossRefPubMed Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One. 2008;3:e2119.PubMedCentralCrossRefPubMed
7.
go back to reference Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013;65:513–8.PubMedCentralCrossRefPubMed Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum. 2013;65:513–8.PubMedCentralCrossRefPubMed
8.
go back to reference Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol. 2008;14:4454–61.PubMedCentralCrossRefPubMed Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol. 2008;14:4454–61.PubMedCentralCrossRefPubMed
9.
go back to reference Rosenzweig HL, Kawaguchi T, Martin TM, Planck SR, Davey MP, Rosenbaum JT. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma. Invest Ophthalmol Vis Sci. 2009;50:1739–45.PubMedCentralCrossRefPubMed Rosenzweig HL, Kawaguchi T, Martin TM, Planck SR, Davey MP, Rosenbaum JT. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma. Invest Ophthalmol Vis Sci. 2009;50:1739–45.PubMedCentralCrossRefPubMed
10.
go back to reference Rosenzweig HL, Galster K, Vance EE, Ensign-Lewis J, Nunez G, Davey MP, et al. NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice. Invest Ophthalmol Vis Sci. 2011;52:4106–12.PubMedCentralCrossRefPubMed Rosenzweig HL, Galster K, Vance EE, Ensign-Lewis J, Nunez G, Davey MP, et al. NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice. Invest Ophthalmol Vis Sci. 2011;52:4106–12.PubMedCentralCrossRefPubMed
11.
go back to reference Rodríguez-Pérez N, Aguinaga-Barrilero A, Gorroño-Echebarría MB, Pérez-Blas M, Martín-Villa JM. Blau syndrome-related CARD15/NOD2 mutations are not linked to idiopathic uveitis in Spanish patients. Dis Markers. 2009;27:1–5.PubMedCentralCrossRefPubMed Rodríguez-Pérez N, Aguinaga-Barrilero A, Gorroño-Echebarría MB, Pérez-Blas M, Martín-Villa JM. Blau syndrome-related CARD15/NOD2 mutations are not linked to idiopathic uveitis in Spanish patients. Dis Markers. 2009;27:1–5.PubMedCentralCrossRefPubMed
12.
go back to reference Rodríguez-Pérez N, Aguinaga-Barrilero A, Gorroño-Echebarría MB, Pérez-Blas M, Martín-Villa JM. Analysis of Crohn's disease-related CARD15 polymorphisms in Spanish patients with idiopathic uveitis. Dis Markers. 2008;24:111–7.PubMedCentralCrossRefPubMed Rodríguez-Pérez N, Aguinaga-Barrilero A, Gorroño-Echebarría MB, Pérez-Blas M, Martín-Villa JM. Analysis of Crohn's disease-related CARD15 polymorphisms in Spanish patients with idiopathic uveitis. Dis Markers. 2008;24:111–7.PubMedCentralCrossRefPubMed
Metadata
Title
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study
Authors
E. Marrani
R. Cimaz
O M Lucherini
R. Caputo
A. Vitale
L. Cantarini
G. Simonini
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2015
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-015-0037-5

Other articles of this Issue 1/2015

Pediatric Rheumatology 1/2015 Go to the issue